B. Lundt

发表

Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B*

Ole Hvilsted Olsen, Sven Branner, O. Olsen, 2000, The Journal of Biological Chemistry.

New β-Alanine Derivatives Are Orally Available Glucagon Receptor Antagonists

C. Behrens, L. B. Knudsen, C. L. Brand, 2007 .

New beta-alanine derivatives are orally available glucagon receptor antagonists.

C. Behrens, L. B. Knudsen, C. L. Brand, 2007, Journal of medicinal chemistry.

Glucagon: structure-function relationships investigated by sequence deletions.

A. Moody, A. Vølund, N. L. Johansen, 1981, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.

K. Raun, K. Madsen, H. Thøgersen, 1998, Journal of medicinal chemistry.

Important role of C-terminal peptide bonds for endothelin receptor binding and activity.

P. Suzdak, J. Weis, K. Madsen, 1993, Pharmacology & toxicology.

Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives.

P. Suzdak, Michael D B Swedberg, J. Lau, 2001, Bioorganic & medicinal chemistry.

Removal of t-butyl and t-butoxycarbonyl protecting groups with trifluoroacetic acid. Mechanisms, biproduct formation and evaluation of scavengers.

A. Vølund, N. L. Johansen, J. Markussen, 2009, International journal of peptide and protein research.

Formation and synthesis of 3'-t-butyltyrosine.

N. L. Johansen, J. Markussen, B. Lundt, 2009, International journal of peptide and protein research.

Oxadiazoles as bioisosteric transformations of carboxylic functionalities. II

C. Braestrup, B. Lundt, A. Jørgensen, 1996 .

The synthesis of novel GABA uptake inhibitors. Part 2. Synthesis of 5-hydroxytiagabine, a human metabolite of the GABA reuptake inhibitor tiagabine

Elaine C. Lee, H. Thøgersen, M. Chorghade, 1994 .

Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.

P. Suzdak, Michael D B Swedberg, R. Henry, 1999, Journal of medicinal chemistry.

Structure-activity relationships of endothelin analogs

P. Suzdak, K. Madsen, H. Thøgersen, 1991 .

Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates.

P. Suzdak, Michael D B Swedberg, J. Sorensen, 1999, Journal of medicinal chemistry.

Synthesis of Novel γ-Aminobutyric Acid (GABA) Uptake Inhibitors. Part 5. Preparation and Structure—Activity Studies of Tricyclic Analogues of Known GABA Uptake Inhibitors.

P. Suzdak, Michael D B Swedberg, J. Lau, 2001 .

Synthesis of novel gamma-aminobutyric acid (GABA) uptake inhibitors. 5.(1) Preparation and structure-activity studies of tricyclic analogues of known GABA uptake inhibitors.

P. Suzdak, Michael D B Swedberg, J. Sorensen, 2001, Journal of medicinal chemistry.

Highly active atrial natriuretic factor (ANF) analogues, lacking the exocyclic N- and C-termini

K. Madsen, H. Thøgersen, N. L. Johansen, 1994 .